Geographically, S. flexneri is the most frequent species occurred worldwide accounting for most
cases in emerging economies. Whereas, the S. sonnei is prevalent in Brazil, China, Vietnam,
and Bangladesh, due to rapid industrialization of these economies. The primary prevention of
Shigella is based on the universal provision of portable sanitation and water methods along
with personal and food hygiene. However, a low cost and effective vaccine would accelerate
disease reduction across the globe.
Joint ventures and collaborations of major players to develop and commercializes the vaccine
are expected to propel the Shigella vaccines market in near future:
Joint ventures and partnership of the players to develop and commercialize Shigella vaccine is
expected to provide momentum to the Shigella vaccines market. For instance, in March 2017,
Hilleman Laboratories, a non-profit organization established with joint venture partnership
between Merck & Co., and Wellcome Trust has entered into an agreement with National
Institute of Cholera and Enteric Disease (NICED) for the development and commercialization of
vaccines against Shigella by 2024. Besides, in June 2016, Immuron- an Australian
biopharmaceutical company entered into an agreement to produce Shigella vaccine with the U.S
Army’s biomedical research lab-Walter Reed Army Institute of Research (WRAIR).
Prokarium and Probiomed in January 2017, collaborated to manufacture orally-administrated
vaccine to prevent diarrhea. The new vaccine is expected to be manufactured as a part of two-
year collaboration having thermostable capabilities for a longer period. The new vaccine is
expected to be delivered to the people living in the remote areas. Thermostable vaccine, which
is manufactured approximately one third of the price of the conventional injectable vaccines
helps to facilities the growth of Shigella vaccines market.
Report includes chapters which deeply display the following deliverable about industry :
• Shigella Vaccines Market Research Objective and Assumption
• Shigella Vaccines Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Shigella Vaccines Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Shigella Vaccines Market, By Regions
• Shigella Vaccines Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Shigella Vaccines Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.